Medicare Enrolled

Dr. Maria Philip, MD

Neurology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6301 GASTON AVE STE 100W, Dallas, TX 75214
2148273610
In practice since 2009 (16 years)
NPI: 1841429057 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Philip from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Philip? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Philip

Dr. Maria Philip is a neurology in Dallas, TX, with 16 years in practice. Based on federal Medicare data, Dr. Philip performed 5,053 Medicare services across 754 unique beneficiaries.

Between the years covered by Open Payments, Dr. Philip received a total of $3,577 from 41 pharmaceutical and/or device companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Philip is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 13% volume in TX$ $3,577 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,053
Medicare services
Top 13% in TX for neurology
754
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~316 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
MRI contrast dye injection (gadoterate)4,060$0$1
Office visit, established patient (30-39 min)320$92$330
Needle measurement of electrical activity in arm or leg muscles, complete study164$77$103
Needle measurement of electrical activity in arm or leg muscles, limited study153$50$66
New patient office visit (45-59 min)140$116$500
Nerve conduction, 9-10 studies65$165$715
Nerve conduction, 7-8 studies53$137$590
Nerve conduction, 5-6 studies34$105$445
Mri scan of brain without contrast19$102$1,115
Office visit, established patient (20-29 min)19$64$225
Mri scan of upper spinal canal without contrast14$84$975
Nerve conduction, 11-12 studies12$183$800
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,577
Total received (2018-2024)
Avg $511/year across 7 years
Top 44% in TX for neurology
41
Companies
233
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,577 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$352
2023
$641
2022
$724
2021
$564
2020
$300
2019
$494
2018
$502

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$778
ABBVIE INC.
$342
Avanir Pharmaceuticals, Inc.
$250
Novartis Pharmaceuticals Corporation
$184
Sunovion Pharmaceuticals Inc.
$181
Amylyx Pharmaceuticals, Inc.
$180
UCB, Inc.
$133
Amgen Inc.
$132
PFIZER INC.
$131
Biogen, Inc.
$113
Merz Pharmaceuticals, LLC
$78
Teva Pharmaceuticals USA, Inc.
$78
EMD Serono, Inc.
$76
Horizon Therapeutics plc
$75
Siemens Medical Solutions USA, Inc.
$64
Upsher-Smith Laboratories LLC
$63
Alexion Pharmaceuticals, Inc.
$57
GENZYME CORPORATION
$57
AbbVie Inc.
$51
Amneal Pharmaceuticals LLC
$49
Avion Pharmaceuticals
$48
SK Life Science, Inc.
$44
Alnylam Pharmaceuticals Inc.
$41
Mitsubishi Tanabe Pharma America, Inc.
$35
Lilly USA, LLC
$33
Janssen Pharmaceuticals, Inc
$32
Assertio Therapeutics, Inc.
$27
ARGENX US, INC.
$27
Eisai Inc.
$22
Neurocrine Biosciences, Inc.
$21
JAZZ PHARMACEUTICALS INC.
$19
Promius Pharma LLC
$19
Impax Laboratories, Inc.
$18
Biohaven Pharmaceutical Holding Company Ltd.
$18
Grifols USA, LLC
$16
GE HEALTHCARE
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Greenwich Biosciences, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
HOSPIRA, INC.
$13
EISAI INC.
$12
Top 3 companies account for 38.3% of total payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BOTOX · Betaseron · Briviact · CAMBIA · COPAXONE · Dhivy · EMGALITY · Enspryng · Epidiolex · FABRY-DISEASE · Fycompa · GAMMAGARD · GILENYA · Gamunex-C · Gralise · INGREZZA · KESIMPTA · KYNMOBI · Mavenclad · NUEDEXTA · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · PANZYGA · POMPE - DISEASE · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELYVRIO · RYTARY · Radicava · SOLIRIS · Skyclarys · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VERSANT kPCR Molecular System SP · VYVGART · Vimpat · XYREM · Xeomin · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $71 per 100 Medicare services performed
Looking for a neurology in Dallas?
Compare neurologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
235
Per 100K population
9.0
County median income
$74,149
Nearest hospital
WHITE ROCK MEDICAL CENTER
2.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Philip is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Philip experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. Philip performed 4,060 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Philip receive payments from pharmaceutical companies?
Yes. Dr. Philip received a total of $3,577 from 41 companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Philip's costs compare to other neurologys in Dallas?
Dr. Philip's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Philip) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →